| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |